Table Graph
      published meta-analysis   sensitivity analysis   studies

corticosteroids in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsClemency, 2021 1.03 [0.02; 52.20] Ezer N (CONTAIN), 2021 0.93 [0.02; 47.48] 0.98[0.06; 15.76]Clemency, 2021, Ezer N (CONTAIN), 202120%603lownot evaluable deathsdetailed resultsClemency, 2021 1.03 [0.02; 52.20] Ezer N (CONTAIN), 2021 0.93 [0.02; 47.48] 0.98[0.06; 15.76]Clemency, 2021, Ezer N (CONTAIN), 202120%603lownot evaluable hospitalization or deathdetailed resultsClemency, 2021 0.39 [0.09; 1.67] 0.39[0.09; 1.67]Clemency, 202110%400NAnot evaluable clinical improvement (14-day)detailed resultsClemency, 2021 1.19 [0.78; 1.81] 1.19[0.78; 1.81]Clemency, 202110%400NAnot evaluable clinical improvement (28-day)detailed resultsClemency, 2021 1.28 [0.84; 1.96] 1.28[0.84; 1.96]Clemency, 202110%400NAnot evaluable clinical improvement (7-day)detailed resultsClemency, 2021 0.92 [0.51; 1.66] 0.92[0.51; 1.66]Clemency, 202110%400NAnot evaluable hospitalizationdetailed resultsEzer N (CONTAIN), 2021 1.92 [0.47; 7.89] 1.92[0.47; 7.89]Ezer N (CONTAIN), 202110%203NAnot evaluable recoverydetailed resultsEzer N (CONTAIN), 2021 1.25 [0.71; 2.22] 1.25[0.71; 2.22]Ezer N (CONTAIN), 202110%203NAnot evaluable adverse eventsdetailed resultsEzer N (CONTAIN), 2021 0.82 [0.43; 1.57] 0.82[0.43; 1.57]Ezer N (CONTAIN), 202110%203NAnot evaluable0.25.01.0relative treatment effectwww.metaEvidence.org2024-11-01 01:06 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 522,582,666,1149,1150,737,544,733 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons